Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity

被引:89
作者
Wang, Xiao-Jun [1 ]
Sun, Zheng [1 ]
Chen, Weirnin [1 ]
Eblin, Kylee E. [1 ]
Gandolfi, Jay A. [1 ]
Zhang, Donna D. [1 ]
机构
[1] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
关键词
Nrf2; keapl; arsenic; arsenite; MMA(III); UROtsa;
D O I
10.1016/j.taap.2007.07.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Arsenic is widely spread in our living environment and imposes a big challenge on human health worldwide. Arsenic damages biological systems through multiple mechanisms including the generation of reactive oxygen species. The transcription factor Nrf2 regulates the cellular antioxidant response that protects cells from various insults. In this study, the protective role of Nrf2 in arsenic toxicity was investigated in a human bladder urothelial cell line, UROtsa. Using a UROtsa cell line stably infected with Nrf2-siRNA, we clearly demonstrate that compromised Nrf2 expression sensitized the cells to As(III)- and MMA(III)-induced toxicity. On the other hand, the activation of the Nrf2 pathway by tert-butylhydroquinone (tBHQ) and sulforaphane (SF), the known Nrf2-inducers, rendered UROtsa cells more resistant to As(III) and MMA(III). Furthermore, the wild-type mouse embryo fibroblast (WT-MEF) cells were protected from As(III)- and MMA(III)-induced toxicity following Nrf2 activation by tBHQ or SF, whereas neither tBHQ nor SF conferred protection in the Nrf2(-/-)MEF cells, demonstrating that tBHQ- or SF-mediated protection against As(III)- and MMA(III)-induced toxicity depends on Nrf2 activation. These results, obtained by both loss of function and gain of function analyses, clearly demonstrate the protective role of Nrf2 in arsenic-induced toxicity. The current work lays the groundwork for using Nrf2 activators for therapeutic and dietary interventions against adverse effects of arsenic. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:206 / 213
页数:8
相关论文
共 73 条
[11]   Epidemiology and etiology of premalignant and malignant urothelial changes [J].
Cohen, SM ;
Shirai, T ;
Steineck, G .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 :105-115
[12]   A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells [J].
De Haan, LHJ ;
Boerboom, AMJF ;
Rietjens, IMCM ;
van Capelle, D ;
De Ruijter, AJM ;
Jaiswal, AK ;
Aarts, JMMJG .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (11) :1597-1603
[13]   REDUCTION AND BINDING OF ARSENATE AND DIMETHYLARSINATE BY GLUTATHIONE - A MAGNETIC-RESONANCE STUDY [J].
DELNOMDEDIEU, M ;
BASTI, MM ;
OTVOS, JD ;
THOMAS, DJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1994, 90 (02) :139-155
[14]   High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes [J].
Enomoto, A ;
Itoh, K ;
Nagayoshi, E ;
Haruta, J ;
Kimura, T ;
O'Connor, T ;
Harada, T ;
Yamamoto, M .
TOXICOLOGICAL SCIENCES, 2001, 59 (01) :169-177
[15]   Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts [J].
Hayashi, A ;
Suzuki, H ;
Itoh, K ;
Yamamoto, M ;
Sugiyama, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (03) :824-829
[16]   Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2•Keap1•CuI3 complex and recruiting Nrf2•Maf to the antioxidant response element enhancer [J].
He, Xiaoqing ;
Chen, Michael G. ;
Lin, Gary X. ;
Ma, Qiang .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (33) :23620-23631
[17]  
Hsueh YM, 1998, J TOXICOL ENV HEAL A, V54, P431, DOI 10.1080/009841098158728
[18]   Regulatory mechanisms of cellular response to oxidative stress [J].
Itoh, K ;
Ishii, T ;
Wakabayashi, N ;
Yamamoto, M .
FREE RADICAL RESEARCH, 1999, 31 (04) :319-324
[19]   Nrf2 signaling in coordinated activation of antioxidant gene expression [J].
Jaiswal, AK .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 (10) :1199-1207
[20]   The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic [J].
Kala, SV ;
Neely, MW ;
Kala, G ;
Prater, CI ;
Atwood, DW ;
Rice, JS ;
Lieberman, MW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33404-33408